ESC 365 - Intravenous antiplatelets: cangrelor is ready for prime time: chairpersons conclusion.

Open Access

Intravenous antiplatelets: cangrelor is ready for prime time: chairpersons conclusion.

Session: Great Debate on STEMI: current controversies on immediate treatment.

Topic: Acute Coronary Syndromes: Antiplatelet Agents

Event: Acute Cardiovascular Care 2018

Congress Presentation

Add to my library

9 more presentations in this session

PCI of non-IRA lesions immediately after primary PCI - PRO.(VIA ZOOM)

Speaker: Professor K. Oldroyd (Glasgow, GB)

PCI of non-IRA lesions immediately after primary PCI - CONTRA.

Speaker: Professor H. Thiele (Leipzig, DE)

PCI of non-IRA lesions immediately after primary PCI - Rebuttal PRO..(VIA ZOOM)

Speaker: Professor K. Oldroyd (Glasgow, GB)

PCI of non-IRA lesions immediately after primary PCI - Rebuttal CONTRA.

Speaker: Professor H. Thiele (Leipzig, DE)

PCI of non-IRA lesions immediately after primary PCI: chairpersons conclusion.

Access the full session

Great Debate on STEMI: current controversies on immediate treatment.

Speakers: Professor K. Oldroyd, Professor H. Thiele, Professor K. Oldroyd, Professor H. Thiele

About the event

Acute Cardiovascular Care 2018

3 March - 5 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources